Don't miss a thing by getting the day's biggest stories sent direct to your inbox A patient at Royal Manchester Children’s Hospital is the first in the north of England to receive a potentially life-saving drug on the NHS .
Zolgensma is a one-off gene therapy that treats Spinal Muscular Atrophy (SMA) - a rare and often fatal genetic disease that causes paralysis, muscle weakness and progressive loss of movement.
It has a list price of £1.79 million per dose, but was made available on the NHS following a landmark deal struck with manufacturers Novartis Gene Therapies, back in March.
The latest data suggests that Zolgensma can provide improvement in motor function for young children with a specific type of SMA and prolong their lives.
Read more on manchestereveningnews.co.uk
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.